616
Participants
Start Date
June 30, 2012
Primary Completion Date
February 28, 2013
Study Completion Date
February 28, 2013
Dexpramipexole
Oral tablet 150 mg given twice daily (BID)
Westmead Hospital, Westmead
UZ Leuven, Leuven
Calvary Health Care Bethlehem, Melbourne
Royal Brisbane and Women's Hospital, Herston
Hospital Universitario de Bellvitge, Barcelona
AZ St-Lucas, Ghent
Columbia University, New York
Research Foundation of the State University of New York, Syracuse
University of Pittsburgh Medical Center, Pittsburgh
Penn State Hershey Medical Center, Hershey
Karolinska Universitetssjukhuset, Solna, Stockholm
Drexel University College of Medicine, Philadelphia
ALS Center at Penn, Philadelphia
Johns Hopkins University School of Medicine, Baltimore
University of Virginia Health System, Charlottesville
Wake Forest University, Winston-Salem
Duke University Medical Center, Durham
Hospital La Paz, Madrid
Carolinas Medical Center, Charlotte
Emory University, Atlanta
Mayo Clinic - Jacksonville, Jacksonville
University of Miami Miller School of Medicine, Miami
University of South Florida Medical Center, Tampa
CHU Gui de Chauliac, Montpellier
Vanderbilt University Medical Center, Nashville
Sahlgrenska Universitetssjukhuset, Gothenburg
Ohio State University, Columbus
The Cleveland Clinic Foundation, Cleveland
Indiana University, Indianapolis
St. Mary's Health Care, Grand Rapids
University of Iowa, Iowa City
Hennepin County Medical Center, Minneapolis
Mayo Clinic - Rochester, Rochester
CHRU de Lille - Hôpital Roger Salengro, Lille
Northwestern University, Chicago
Washington University School of Medicine, St Louis
University of Kansas Medical Center, Kansas City
Neurology Associates, P.C., Lincoln
Hôpital La Pitié Salpétrière, Paris
Texas Neurology, Dallas
Methodist Neurological Institute, Houston
University of Texas Health Sciences Center, San Antonio
University of Utah, Salt Lake City
Barrow Neurological Institute - St. Joseph's Hospital, Phoenix
University of Nevada School of Medicine, Las Vegas
University of California, Irvine, Orange
California Pacific Medical Center, San Francisco
University of California, Davis, Sacramento
Providence ALS Center, Portland
University of Washington, Seattle
University of California at San Francisco - Fresno, Fresno
Hospital for Special Care, New Britain
Massachusetts General Hospital, Charlestown
Dartmouth-Hitchcock Medical Center, Lebanon
Prince of Wales Hospital, Randwick
London Health Sciences Centre, London
University of British Columbia, Vancouver
Centre Hospitalier La Timone, Marseille
CHU de Nice - Hôpital de l'Archet 1, Nice
Charité - Universitätsmedizin Berlin, Berlin
Bergmannsheil Gmbh, Bochum
Medizinische Hochschule Hannover (MHH), Hanover
Universitätsklinikum Jena, Jena
University of Ulm, RKU, Ulm
Hospital Vall d'Hebron, Barcelona
Hospital Carlos III, Madrid
John Radcliffe Hospital, Oxford
Univ of Calgary / Foothills MC, Calgary
CHUM - Hopital Notre Dame, Montreal
Mcgill University, Montreal
Sunnybrook and Women's College and Health Sciences Centre, Toronto
Beaumont Hospital, Dublin
Academisch Medisch Centrum, Amsterdam
UMC St. Radboud, Nijmegen
Universitair Medisch Centrum Utrecht, Utrecht
Queen Elizabeth Hospital, Birmingham
Walton Centre for Neurology & Neurosurgery, Liverpool
Kings College Hospital NHS Foundation Trust, London
Newcastle University Hospital - Clinical Ageing Research Unit, Newcastle
Sheffield Institute for Transnational Neuroscience, Sheffield
Lead Sponsor
Collaborators (1)
Biogen
INDUSTRY
Knopp Biosciences
INDUSTRY